Moran Wealth Management LLC Has $6.31 Million Stake in Veeva Systems Inc. $VEEV

Moran Wealth Management LLC trimmed its position in shares of Veeva Systems Inc. (NYSE:VEEVFree Report) by 1.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,918 shares of the technology company’s stock after selling 346 shares during the quarter. Moran Wealth Management LLC’s holdings in Veeva Systems were worth $6,312,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the company. TFB Advisors LLC lifted its holdings in shares of Veeva Systems by 1.2% during the 1st quarter. TFB Advisors LLC now owns 3,586 shares of the technology company’s stock valued at $831,000 after buying an additional 44 shares during the last quarter. Triangle Securities Wealth Management lifted its holdings in Veeva Systems by 0.8% in the 2nd quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock worth $1,665,000 after purchasing an additional 45 shares during the last quarter. Marks Group Wealth Management Inc lifted its holdings in Veeva Systems by 3.3% in the 1st quarter. Marks Group Wealth Management Inc now owns 1,427 shares of the technology company’s stock worth $331,000 after purchasing an additional 46 shares during the last quarter. Harbour Investments Inc. lifted its holdings in Veeva Systems by 7.6% in the 1st quarter. Harbour Investments Inc. now owns 789 shares of the technology company’s stock worth $183,000 after purchasing an additional 56 shares during the last quarter. Finally, Parallel Advisors LLC lifted its holdings in Veeva Systems by 4.7% in the 2nd quarter. Parallel Advisors LLC now owns 1,236 shares of the technology company’s stock worth $356,000 after purchasing an additional 56 shares during the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Veeva Systems Price Performance

Shares of VEEV stock opened at $287.81 on Wednesday. The stock’s fifty day simple moving average is $283.06 and its 200 day simple moving average is $265.77. The firm has a market cap of $47.17 billion, a price-to-earnings ratio of 59.10, a P/E/G ratio of 2.21 and a beta of 0.98. Veeva Systems Inc. has a one year low of $201.54 and a one year high of $310.50.

Veeva Systems (NYSE:VEEVGet Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.90 by ($0.64). The company had revenue of $789.08 million during the quarter, compared to analyst estimates of $768.49 million. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. Veeva Systems’s quarterly revenue was up 16.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, research analysts anticipate that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Analysts Set New Price Targets

VEEV has been the topic of several recent analyst reports. Needham & Company LLC lifted their price target on Veeva Systems from $300.00 to $355.00 and gave the stock a “buy” rating in a research report on Thursday, August 28th. Truist Financial lifted their price target on Veeva Systems from $268.00 to $275.00 and gave the stock a “hold” rating in a research report on Thursday, August 28th. Wall Street Zen raised Veeva Systems from a “hold” rating to a “buy” rating in a research report on Saturday. TD Cowen upgraded Veeva Systems from a “hold” rating to a “buy” rating and boosted their price objective for the company from $297.00 to $380.00 in a research report on Tuesday, October 7th. Finally, Wells Fargo & Company boosted their price objective on Veeva Systems from $300.00 to $326.00 and gave the company an “overweight” rating in a research report on Tuesday, August 26th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $307.58.

Read Our Latest Stock Report on Veeva Systems

Insiders Place Their Bets

In other Veeva Systems news, insider Eleni Nitsa Zuppas sold 6,000 shares of the business’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the transaction, the insider owned 25,325 shares of the company’s stock, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Thomas D. Schwenger sold 3,350 shares of the business’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the transaction, the insider directly owned 23,773 shares in the company, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 24,665 shares of company stock valued at $7,438,000. 10.30% of the stock is currently owned by corporate insiders.

About Veeva Systems

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

See Also

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEVFree Report).

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.